Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020109251 - DOSAGE REGIME

Publication Number WO/2020/109251
Publication Date 04.06.2020
International Application No. PCT/EP2019/082464
International Filing Date 25.11.2019
IPC
A61K 47/50 2017.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
A61K 45/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
CPC
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K 47/50
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • ADC THERAPEUTICS SA [CH]/[CH]
  • MEDIMMUNE LIMITED [GB]/[GB]
Inventors
  • FEINGOLD, Jay Marshall
  • UNGAR, David Rodney
Agents
  • MEWBURN ELLIS LLP
Priority Data
62/772,92729.11.2018US
62/866,98226.06.2019US
62/883,86707.08.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) DOSAGE REGIME
(FR) RÉGIME POSOLOGIQUE
Abstract
(EN)
The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to particular dosage regimens for the administration of ADCs which bind to CD19 (CD19-ADCs).
(FR)
La présente invention concerne le traitement d'états pathologiques, tels que le cancer, avec des conjugués anticorps-médicaments (CAM). En particulier, la présente invention concerne de nouveaux régimes posologiques pour l'administration de CAM qui se lient à CD19 (CAM-CD19).
Latest bibliographic data on file with the International Bureau